Immunity to Murine Sarcoma Virus-Induced Tumors

Abstract
Experiments have been performed to examine the immune status in animals carrying tumors which are in their progressive phase of growth. Unfractionated spleen or lymph node cells of BALB/c mice, inoculated 10 to 14 days previously with murine sarcoma virus (MSV), have no demonstrable immunity in vitro to MSV-viral antigens. On fractionation of the spleen cells from such animals, however, large and small cells can be detected which react in well defined assays for immunity in this system. A cell population of intermediate size is capable of suppressing this activity. Treatment of the suppressing cell population with anti-θ or anti-immunoglobulin antiserum has provided data to suggest that the suppression is caused by a cell with immunoglobulin moieties on its surface. Moreover, evidence is presented to show that this suppression is nonspecific, in that the induction of protein synthesis in thymus-associated (T) cells in response to the mitogen phytohemagglutinin (PHA) is also suppressed by a cell with the above characteristics. The significance of these findings in relation to the status of growth of the tumor in the host is discussed.